文献速递角膜与眼表疾病眼整形与眼眶

泪腺原发性上皮性恶性肿瘤眼眶放疗后的角膜并发症

Corneal complications after orbital radiotherapy for primary epithelial malignancies of the lacrimal gland.
PubMed 文献 · Br J Ophthalmol · 2017-10-19

回顾性病例系列纳入1975至2014年在Moorfields眼科医院因泪腺原发性上皮性癌接受高剂量外照射眼眶放疗的67例患者,9例(13%)发生角膜穿孔,中位时间10.4个月,多数在36个月内;全队列平均随访8.2年。结论认为多数保眼治疗患者未发生角膜穿孔,但通常需长期治疗维持眼表。

要点

  • 67例接受高剂量外照射眼眶放疗的泪腺癌患者中9例(13%)发生角膜穿孔。
  • 角膜穿孔中位时间10.4个月(均值35,范围3.2个月至14.5年),7/9(78%)在放疗后36个月内穿孔。
  • 全队列平均随访8.2年(中位4.6,范围2个月至30.7年),多数保眼治疗患者未发生角膜穿孔。

核心结论

  • 多数接受保眼治疗的泪腺癌患者未发生角膜穿孔,但通常需要长期治疗以维持眼表。
  • 泪腺癌所需的高剂量外照射放疗可造成显著的眼表病变,角膜穿孔发生率为13%,在放疗后前3年内最高。

研究设计与样本

  • 回顾性病例系列,纳入1975至2014年在Moorfields眼科医院接受外照射放疗的泪腺原发性上皮性癌患者,回顾眼科病历及肿瘤科与全科医生记录。

主要发现

  • 67例患者中9例(13%)发生角膜穿孔,中位时间10.4个月(均值35,范围3.2个月至14.5年)。
  • 9例角膜穿孔中7例(78%)发生在放疗后36个月内。
  • 全队列平均随访8.2年(中位4.6,范围2个月至30.7年)。

临床怎么用

  • 原文结论指出多数保眼治疗的泪腺癌患者未发生角膜穿孔,但通常需要长期治疗以维持眼表。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To review the long-term corneal complications after high-dose external beam orbital radiotherapy given to patients for lacrimal gland carcinomas. The impact of prophylactic measures to improve long-term ocular surface health is also assessed. DESIGN: Retrospective case series. PARTICIPANTS: Patients under the care of Moorfields Eye Hospital and receiving external beam radiotherapy for primary epithelial lacrimal gland carcinoma between 1975 and 2014. METHODS: Retrospective review of ophthalmic case notes at Moorfields Eye Hospital, and oncology and general physician records. MAIN OUTCOME MEASURES: The occurrence of corneal perforation, and time to perforation. RESULTS: Sixty-seven patients were included in this study, of whom nine (13%) developed corneal perforation at a median time of 10.4 months after radiotherapy (mean 35; range 3.2 months to 14.5 years); the majority (7/9; 78%) perforated within 36 months of radiotherapy. The mean follow-up interval of the whole cohort was 8.2 years (median 4.6; range, 2 months to 30.7 years). CONCLUSIONS: Although most patients with globe-sparing treatment of lacrimal gland carcinoma did not suffer corneal perforation, they usually require long-term therapy to maintain the ocular surface. The high-dose external beam radiotherapy needed for lacrimal gland carcinoma can produce significant ocular surface morbidity, and the 13% incidence of corneal perforation was greatest in the first 3 years after irradiation.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Gore SK, Plowman NP, Dharmasena A, et al. Corneal complications after orbital radiotherapy for primary epithelial malignancies of the lacrimal gland. Br J Ophthalmol. 2017. PMID: 29051324. doi:10.1136/bjophthalmol-2017-311134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。